Preview Mode Links will not work in preview mode

Professionally Cannabis & Psychedelics

Sep 30, 2021

Tune into this week’s pod with one of the OGs of cannabis research - Professor Roger Pertwee, Emeritus Professor at the University of Aberdeen.

In no uncertain terms, across over 50 years of cannabis research, Roger is behind many of the scientific breakthroughs that underpin our understanding of the pharmacology of...


Sep 23, 2021

Earlier this year, we spoke with another psychedelics and cannabis pioneer, Ronan Levy, Co-Founder & Executive Chairman of Field Trip Health.


Within a candid conversation, Ronan discusses how Field Trip have exponentially scaled their business, the differences and similarities between how the psychedelics and cannabis...


Sep 16, 2021

Earlier this year, we spoke with Peter Crock, the CEO of Australian cannabis operator, Cann Group Ltd.

As the first company in Australia granted a cultivation and research license for medical cannabis, Peter talks through the current state of play in the domestic market, Cann Group’s acquisitions and expansion into...


Sep 9, 2021

For this episode, we speak with cannabis and psychedelics investors, Bek Muslimov and Nikolay Tretiyakov of Leafy Tunnel.

Over the interview, we hear about the similarities and differences between cannabis and psychedelics investing, what investors should look for in companies and their founders, and the sectors that...


Sep 8, 2021

Earlier this year, we caught up with returning guest to the pod and a psychedelics and cannabis pioneer, Bruce Linton.

 

Over the interview, Bruce takes us through his journey into psychedelics and gives his insight into public policy, the future of mental health treatment and how investors should approach...